Accelerated dosing schedule with ustekinumab in anti-TNF refractory Crohn's disease

被引：0
|
作者：
Gonzalez, H. Aleman [1 ]
Stamp, K. [1 ]
Whitehead, E. [1 ]
Pattinson, A. [1 ]
Turnbull, J. [1 ]
Myers, S. [1 ]
Talbot, A. [1 ]
Sebastian, S. [1 ]
机构：
[1] Hull Univ Teaching Hosp, Inflammatory Bowel Dis, Kingston Upon Hull, Yorks, England
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P372
引用
收藏
页码：I374 / I375
页数：2
相关论文
共 50 条
  • [1] Accelerated dosing schedule with ustekinumab in anti-TNF refractory Crohn's disease
    Gonzalez, H. Aleman
    Stamp, K.
    Whitehead, E.
    Pattinson, A.
    Turnbull, J.
    Myers, S.
    Talbot, A.
    Sebastian, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I374 - I375
  • [2] ACCELERATED DOSING SCHEDULE WITH USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE
    Gonzalez, Haidee Aleman
    Stamp, Katie
    Whitehead, Emma
    Myers, Sally
    Turnbull, Jack
    Pattinson, Alison
    Talbot, Alison
    Sebastian, Shaji
    [J]. GUT, 2021, 70 : A98 - A98
  • [3] Effectiveness of ustekinumab in fistulising perianal Crohn's disease refractory or intolerant to anti-TNF
    Carpio, D.
    Calvino-Suarez, C.
    Martinez-Cadilla, J.
    Molina, G.
    Vazquez-Rey, M. T.
    Marti, E.
    Fernandez-Salgado, E.
    Acosta, M. Barreiro-de
    Hernandez, V.
    Echarri, A.
    Diz-Lois, M. T.
    Baz, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S419 - S420
  • [4] The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
    Kassouri, Liza
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1148 - 1155
  • [5] Report of successful use of ustekinumab in Crohn's disease refractory to three anti-TNF therapies
    Heetun, Z. S.
    Keegan, D.
    O'Donoghue, D.
    Doherty, G. A.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 (03) : 507 - 508
  • [6] Report of successful use of ustekinumab in Crohn’s disease refractory to three anti-TNF therapies
    Z. S. Heetun
    D. Keegan
    D. O’Donoghue
    G. A. Doherty
    [J]. Irish Journal of Medical Science (1971 -), 2014, 183 : 507 - 508
  • [7] Open Label Ustekinumab for the Treatment of Anti-TNFα Refractory Moderate-to-Severe Crohn's Disease
    Rosen, Melissa
    Scherl, Ellen
    Rotman, Stephen
    Bosworth, Brian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S486 - S487
  • [8] Assessment of Anti-TNF dosing patterns in adults with Crohn's Disease
    Waters, H.
    Rey, Gomez G.
    Chastek, B.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S19 - S19
  • [9] Assessment of Anti-TNF Dosing Patterns in Adults with Crohn's Disease
    Waters, Heidi
    Rey, Gabriel
    Chastek, Benjamin
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S416 - S417
  • [10] Efficacy of ustekinumab in patient with Crohn's disease and anti-TNF induced psoriasis
    Moreno-Suarez, Fatima
    del Carmen Salazar-Nievas, Maria
    Aceituno-Madera, Pedro
    Bautista-Martinez, Pablo
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB121 - AB121
12345